106 related articles for article (PubMed ID: 16550020)
1. Epstein-Barr Virus-negative posttransplant lymphoproliferative disorder with coexisting native renal cell carcinoma: PET/CT demonstration.
Nguyen BD; Ram PC; Roarke MC
Clin Nucl Med; 2006 Apr; 31(4):218-20. PubMed ID: 16550020
[TBL] [Abstract][Full Text] [Related]
2. 18 F-FDG PET/CT in Renal Allograft Tuberculosis Mimicking as Posttransplant Malignancy.
Moideen A; Singh H; Kumar R; Naik SM; Gupta A; Sekar A; Nada R
Clin Nucl Med; 2024 Feb; 49(2):e52-e53. PubMed ID: 38049975
[TBL] [Abstract][Full Text] [Related]
3. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
Akar Özkan E; Özdemir BH; Deniz EE; Tunca MZ; Haberal M
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813
[TBL] [Abstract][Full Text] [Related]
4. Computed tomography of renal cell carcinoma in patients with terminal renal impairment.
Ferda J; Hora M; Hes O; Reischig T; Kreuzberg B; Mírka H; Ferdová E; Ohlídalová K; Baxa J; Urge T
Eur J Radiol; 2007 Aug; 63(2):295-301. PubMed ID: 17324547
[TBL] [Abstract][Full Text] [Related]
5. Primary Cutaneous Polymorphic EBV-Associated Posttransplant Lymphoproliferative Disorder After a Renal Transplant and Review of the Literature.
Ferguson NN; Thomas CP; Hohl RJ; Syrbu SI; Stone MS; Wanat KA
Am J Dermatopathol; 2015 Oct; 37(10):790-4. PubMed ID: 25747810
[TBL] [Abstract][Full Text] [Related]
6. FDG PET/CT Findings of Renal Cell Carcinoma Arising From a Transplanted Kidney in a Pediatric Patient.
Fleury AS; Zhuang H
Clin Nucl Med; 2023 Dec; 48(12):e605-e607. PubMed ID: 37844572
[TBL] [Abstract][Full Text] [Related]
7. Posttransplant lymphoproliferative disorder with lung involvement in a renal transplant recipient.
Mirza EI; Mutluay R; Suyani E; Okyay GU; Akyurek N; Aki SZ; Derici U; Arinsoy T
Exp Clin Transplant; 2011 Dec; 9(6):425-8. PubMed ID: 22142053
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow involvement by lymphoproliferative disorders after solid-organ transplant.
Akar Özkan E; Özdemir BH; Yılmaz Akçay E; Terzi A; Karakuş S; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():183-7. PubMed ID: 25894151
[TBL] [Abstract][Full Text] [Related]
9. Detection of Epstein-Barr virus DNA in sequential renal transplant biopsy specimens using the polymerase chain reaction. Report of a patient with a posttransplant lymphoproliferative disorder.
Lager DJ; Slagel DD; Burgart LJ
Arch Pathol Lab Med; 1993 Mar; 117(3):308-12. PubMed ID: 8382918
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced ultrasound findings of post-transplant lymphoproliferative disorder in a transplanted kidney: A case report and literature review.
Lampe A; Duddalwar VA; Djaladat H; Aron M; Gulati M
J Radiol Case Rep; 2015 Oct; 9(10):26-34. PubMed ID: 26629291
[TBL] [Abstract][Full Text] [Related]
11. Rituximab therapy and reduction of immunosuppression to rescue graft function after renal posttransplantation lymphoproliferative disorder found by macrohematuria in a pancreas and kidney transplant recipient: a case report.
Miyagi S; Sekiguchi S; Kawagishi N; Akamatsu Y; Satoh K; Takeda I; Fukushima D; Kobayashi Y; Tokodai K; Fujimori K; Satomi S
Transplant Proc; 2011 Nov; 43(9):3299-301. PubMed ID: 22099782
[TBL] [Abstract][Full Text] [Related]
12. Renal Squamous Cell Carcinoma of a Native Kidney After Renal Transplant: A Case Report.
Jakes A; Jani P; Menon M; Adams K; Edey M; Fleming S; Bhandari S
Transplant Proc; 2016; 48(1):259-61. PubMed ID: 26915879
[TBL] [Abstract][Full Text] [Related]
13. Clinical usefulness of FDG-PET/CT scan imaging in the management of posttransplant lymphoproliferative disease.
Bianchi E; Pascual M; Nicod M; Delaloye AB; Duchosal MA
Transplantation; 2008 Mar; 85(5):707-12. PubMed ID: 18337664
[TBL] [Abstract][Full Text] [Related]
14. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations.
Walker RC; Paya CV; Marshall WF; Strickler JG; Wiesner RH; Velosa JA; Habermann TM; Daly RC; McGregor CG
J Heart Lung Transplant; 1995; 14(2):214-21. PubMed ID: 7779838
[TBL] [Abstract][Full Text] [Related]
15. Renal cell carcinoma coexisting with acquired cystic disease of the kidney in renal transplant patients (two case reports).
Shindo J; Takeuchi I; Chikaraishi T; Seki T; Morita K; Harada H; Watarai Y; Nonomura K; Koyanagi T
Transplant Proc; 1998 Nov; 30(7):3159-61. PubMed ID: 9838397
[No Abstract] [Full Text] [Related]
16. Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection?
Burra P; Buda A; Livi U; Rigotti P; Zanus G; Calabrese F; Caforio A; Menin C; Canova D; Farinati F; Luciana Aversa SM
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1065-70. PubMed ID: 16957512
[TBL] [Abstract][Full Text] [Related]
17. Posttransplant lymphoproliferative disorder in pediatric bone marrow transplant recipients: disseminated disease of donor origin demonstrated by fluorescence in situ hybridization.
Lones MA; Lopez-Terrada D; Shintaku IP; Rosenthal J; Said JW
Arch Pathol Lab Med; 1998 Aug; 122(8):708-14. PubMed ID: 9701332
[TBL] [Abstract][Full Text] [Related]
18. De novo renal cell carcinoma of native kidney in renal transplant recipients.
Neuzillet Y; Lay F; Luccioni A; Daniel L; Berland Y; Coulange C; Lechevallier E
Cancer; 2005 Jan; 103(2):251-7. PubMed ID: 15593084
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of posttransplant lymphoproliferative disorder with renal graft preservation by monoclonal antibody therapy.
Antoine C; Garnier JL; Duboust A; Bariéty J; Stevenson G; Glotz D
Transplant Proc; 1996 Oct; 28(5):2825-6. PubMed ID: 8908082
[No Abstract] [Full Text] [Related]
20. Metastatic malignant tumor in native kidney with acquired cystic disease after renal transplantation.
Garcia de la Oliva T; Gonzalez Molina M
Eur J Radiol; 1990; 11(2):154-5. PubMed ID: 2253639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
